Ultimately power can only be calculated under an alternative model. Thus on a practical level the optimal choice of assays and sample sizes will actually depend on the researcher's belief regarding the unknown distribution of effect sizes and models relating genotype and phenotype. In particular we show that one might adopt different strategies depending on the expected frequency of disease causing variant, the effect size and even the population from which cases and controls are sampled (Figure 3).
